JP5632749B2 - 組織工学足場 - Google Patents
組織工学足場 Download PDFInfo
- Publication number
- JP5632749B2 JP5632749B2 JP2010546939A JP2010546939A JP5632749B2 JP 5632749 B2 JP5632749 B2 JP 5632749B2 JP 2010546939 A JP2010546939 A JP 2010546939A JP 2010546939 A JP2010546939 A JP 2010546939A JP 5632749 B2 JP5632749 B2 JP 5632749B2
- Authority
- JP
- Japan
- Prior art keywords
- tubular element
- elastic
- scaffold
- natural
- tensile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 claims description 131
- 239000000835 fiber Substances 0.000 claims description 56
- 229920000954 Polyglycolide Polymers 0.000 claims description 48
- 238000001523 electrospinning Methods 0.000 claims description 48
- 239000004633 polyglycolic acid Substances 0.000 claims description 48
- 108010035532 Collagen Proteins 0.000 claims description 40
- 102000008186 Collagen Human genes 0.000 claims description 40
- 229920001436 collagen Polymers 0.000 claims description 40
- 239000004814 polyurethane Substances 0.000 claims description 40
- 229920001072 poly(l-lactide-co-caprolactone) Polymers 0.000 claims description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 30
- 108010014258 Elastin Proteins 0.000 claims description 30
- 102000016942 Elastin Human genes 0.000 claims description 30
- 229920002549 elastin Polymers 0.000 claims description 29
- 239000004816 latex Substances 0.000 claims description 25
- 229920000126 latex Polymers 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 21
- -1 polyethylene terephthalate Polymers 0.000 claims description 21
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 17
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 16
- 229920001610 polycaprolactone Polymers 0.000 claims description 16
- 239000004632 polycaprolactone Substances 0.000 claims description 16
- OYQYHJRSHHYEIG-UHFFFAOYSA-N ethyl carbamate;urea Chemical compound NC(N)=O.CCOC(N)=O OYQYHJRSHHYEIG-UHFFFAOYSA-N 0.000 claims description 15
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 10
- 229920004934 Dacron® Polymers 0.000 claims description 9
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 9
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 229920000544 Gore-Tex Polymers 0.000 claims description 7
- 102000011782 Keratins Human genes 0.000 claims description 7
- 108010076876 Keratins Proteins 0.000 claims description 7
- 239000004677 Nylon Substances 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 229920001778 nylon Polymers 0.000 claims description 7
- 229920000728 polyester Polymers 0.000 claims description 7
- 229920002781 resilin Polymers 0.000 claims description 7
- 108010030147 Abductin Proteins 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 108010019116 resilin Proteins 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 114
- 210000001519 tissue Anatomy 0.000 description 105
- 210000004204 blood vessel Anatomy 0.000 description 72
- 239000000463 material Substances 0.000 description 72
- 239000010410 layer Substances 0.000 description 71
- 230000002792 vascular Effects 0.000 description 40
- 229920002635 polyurethane Polymers 0.000 description 32
- 230000004044 response Effects 0.000 description 32
- 239000000243 solution Substances 0.000 description 32
- 238000010899 nucleation Methods 0.000 description 31
- 239000011148 porous material Substances 0.000 description 30
- 238000010586 diagram Methods 0.000 description 29
- 230000007704 transition Effects 0.000 description 26
- 210000002889 endothelial cell Anatomy 0.000 description 24
- 239000000203 mixture Substances 0.000 description 19
- 210000001367 artery Anatomy 0.000 description 18
- 230000003750 conditioning effect Effects 0.000 description 18
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 16
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 16
- 230000003938 response to stress Effects 0.000 description 16
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000001965 increasing effect Effects 0.000 description 13
- 208000024172 Cardiovascular disease Diseases 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 11
- 238000003860 storage Methods 0.000 description 11
- 206010053567 Coagulopathies Diseases 0.000 description 10
- 238000005266 casting Methods 0.000 description 10
- 230000035602 clotting Effects 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 238000000151 deposition Methods 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000010186 staining Methods 0.000 description 9
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 8
- 230000008878 coupling Effects 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 238000012258 culturing Methods 0.000 description 8
- 108010082117 matrigel Proteins 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000012620 biological material Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000001143 conditioned effect Effects 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000001715 carotid artery Anatomy 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 230000000541 pulsatile effect Effects 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 108010067306 Fibronectins Proteins 0.000 description 5
- 102000016359 Fibronectins Human genes 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 230000009044 synergistic interaction Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000003038 endothelium Anatomy 0.000 description 4
- 210000001105 femoral artery Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 238000009864 tensile test Methods 0.000 description 4
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010002329 Aneurysm Diseases 0.000 description 3
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 210000002403 aortic endothelial cell Anatomy 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 239000013013 elastic material Substances 0.000 description 3
- 239000013536 elastomeric material Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 210000004731 jugular vein Anatomy 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000003763 resistance to breakage Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 2
- LLLVZDVNHNWSDS-UHFFFAOYSA-N 4-methylidene-3,5-dioxabicyclo[5.2.2]undeca-1(9),7,10-triene-2,6-dione Chemical compound C1(C2=CC=C(C(=O)OC(=C)O1)C=C2)=O LLLVZDVNHNWSDS-UHFFFAOYSA-N 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 101710145505 Fiber protein Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 241000761557 Lamina Species 0.000 description 2
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000001736 capillary Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000002434 celiac artery Anatomy 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000008614 cellular interaction Effects 0.000 description 2
- 210000002358 circulating endothelial cell Anatomy 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000007787 electrohydrodynamic spraying Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 210000003090 iliac artery Anatomy 0.000 description 2
- 210000003111 iliac vein Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000003975 mesenteric artery Anatomy 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 210000002254 renal artery Anatomy 0.000 description 2
- 210000002796 renal vein Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 210000003270 subclavian artery Anatomy 0.000 description 2
- 210000001321 subclavian vein Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- 239000003190 viscoelastic substance Substances 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- BGWLYQZDNFIFRX-UHFFFAOYSA-N 5-[3-[2-[3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-phenylphenanthridin-5-ium-3,8-diamine;dichloride Chemical compound [Cl-].[Cl-].C=1C(N)=CC=C(C2=CC=C(N)C=C2[N+]=2CCCNCCNCCC[N+]=3C4=CC(N)=CC=C4C4=CC=C(N)C=C4C=3C=3C=CC=CC=3)C=1C=2C1=CC=CC=C1 BGWLYQZDNFIFRX-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283081 Balaenoptera physalus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000817629 Homo sapiens Dymeclin Proteins 0.000 description 1
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
- 241001325354 Lamiinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 101710161649 Pro-resilin Proteins 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 241000231739 Rutilus rutilus Species 0.000 description 1
- 206010059054 Shunt thrombosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920001872 Spider silk Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102100030859 Tissue factor Human genes 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000004618 arterial endothelial cell Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003678 bronchial smooth muscle cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000005119 human aortic smooth muscle cell Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229920003008 liquid latex Polymers 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001349 mammary artery Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001982 poly(ester urethane) Polymers 0.000 description 1
- 229920001691 poly(ether urethane) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002459 porosimetry Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 210000002163 scaffold cell Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000003894 surgical glue Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001644 umbilical artery Anatomy 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/20—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
- B32B37/02—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by a sequence of laminating steps, e.g. by adding new layers at consecutive laminating stations
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0076—Electro-spinning characterised by the electro-spinning apparatus characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D7/00—Collecting the newly-spun products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1002—Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2886008P | 2008-02-14 | 2008-02-14 | |
| US61/028,860 | 2008-02-14 | ||
| PCT/US2009/034137 WO2009103012A1 (en) | 2008-02-14 | 2009-02-13 | Tissue engineering scaffolds |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014024053A Division JP5978425B2 (ja) | 2008-02-14 | 2014-02-12 | 組織工学足場 |
| JP2014160094A Division JP2015006400A (ja) | 2008-02-14 | 2014-08-06 | 組織工学足場 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011512201A JP2011512201A (ja) | 2011-04-21 |
| JP5632749B2 true JP5632749B2 (ja) | 2014-11-26 |
Family
ID=40957289
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010546939A Expired - Fee Related JP5632749B2 (ja) | 2008-02-14 | 2009-02-13 | 組織工学足場 |
| JP2014024053A Expired - Fee Related JP5978425B2 (ja) | 2008-02-14 | 2014-02-12 | 組織工学足場 |
| JP2014160094A Withdrawn JP2015006400A (ja) | 2008-02-14 | 2014-08-06 | 組織工学足場 |
| JP2016154306A Withdrawn JP2016187640A (ja) | 2008-02-14 | 2016-08-05 | 組織工学足場 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014024053A Expired - Fee Related JP5978425B2 (ja) | 2008-02-14 | 2014-02-12 | 組織工学足場 |
| JP2014160094A Withdrawn JP2015006400A (ja) | 2008-02-14 | 2014-08-06 | 組織工学足場 |
| JP2016154306A Withdrawn JP2016187640A (ja) | 2008-02-14 | 2016-08-05 | 組織工学足場 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090227026A1 (enExample) |
| EP (1) | EP2249742B1 (enExample) |
| JP (4) | JP5632749B2 (enExample) |
| KR (1) | KR101669292B1 (enExample) |
| CN (2) | CN102006837B (enExample) |
| AU (1) | AU2009214508B2 (enExample) |
| CA (1) | CA2715642C (enExample) |
| WO (1) | WO2009103012A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100070020A1 (en) * | 2008-06-11 | 2010-03-18 | Nanovasc, Inc. | Implantable Medical Device |
| US8795577B2 (en) | 2007-11-30 | 2014-08-05 | Cook Medical Technologies Llc | Needle-to-needle electrospinning |
| CA2778459C (en) | 2009-10-28 | 2016-08-16 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Bioerodible wraps and uses therefor |
| US8637109B2 (en) * | 2009-12-03 | 2014-01-28 | Cook Medical Technologies Llc | Manufacturing methods for covering endoluminal prostheses |
| WO2011082295A2 (en) | 2009-12-31 | 2011-07-07 | Neograft Technologies, Inc. | Graft devices and methods of fabrication |
| US8613880B2 (en) | 2010-04-21 | 2013-12-24 | Abbott Cardiovascular Systems Inc. | Post electron beam conditioning of polymeric medical devices |
| CN106267352A (zh) | 2010-05-03 | 2017-01-04 | 再生医学（开曼）有限公司 | 平滑肌细胞结构 |
| CN101850600B (zh) * | 2010-05-14 | 2012-05-23 | 中山大学 | 具有多级孔结构的组织工程管状支架的制作方法及模具 |
| US20110297735A1 (en) * | 2010-06-02 | 2011-12-08 | Medinol, Ltd. | Method and apparatus for stent manufacturing assembly |
| US9445874B2 (en) | 2010-07-19 | 2016-09-20 | Neograft Technologies, Inc. | Graft devices and methods of use |
| US9539360B2 (en) | 2011-10-07 | 2017-01-10 | W. L. Gore & Associaes, Inc. | Puncturable and resealable graft |
| CN102512707A (zh) * | 2011-11-04 | 2012-06-27 | 无锡中科光远生物材料有限公司 | 一种用于制备肌肉肌腱复合组织的支架及其制备方法 |
| US9175427B2 (en) | 2011-11-14 | 2015-11-03 | Cook Medical Technologies Llc | Electrospun patterned stent graft covering |
| US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
| HK1217663A1 (zh) * | 2013-01-09 | 2017-01-20 | Harvard Apparatus Regenerative Technology, Inc. | 合成支架 |
| CN103173931B (zh) * | 2013-03-07 | 2016-04-06 | 苏州睿研纳米医学科技有限公司 | 生物相容的纤维复合无纺网毡及其制备方法和应用 |
| SG10201404111VA (en) | 2013-07-16 | 2015-02-27 | Univ Nanyang Tech | Method for preparing a patterned substrate and use thereof in implants for tissue engineering |
| JP5747098B2 (ja) * | 2014-03-27 | 2015-07-08 | 京セラメディカル株式会社 | 人工関節置換術用手術装置 |
| CN104018245B (zh) * | 2014-06-13 | 2016-11-02 | 东华大学 | 一种丝素蛋白/角蛋白复合纳米纤维管状材料的制备方法 |
| CN104005179A (zh) * | 2014-06-13 | 2014-08-27 | 东华大学 | 一种聚己内酯-角蛋白复合纳米纤维管的制备方法 |
| JP6691921B2 (ja) * | 2015-02-20 | 2020-05-13 | ウィスコンシン アラムニ リサーチ ファンデーション | 動脈内皮細胞集団の生成 |
| CN105031735B (zh) * | 2015-06-24 | 2018-01-19 | 东华大学 | 一种三层复合结构小口径人工血管及其制备方法 |
| CN105343936B (zh) * | 2015-11-05 | 2019-01-01 | 深圳市第二人民医院 | 一种plcl三维多孔支架、plcl-col复合支架及其制备方法 |
| US11414635B2 (en) | 2016-04-18 | 2022-08-16 | Saint Louis University | Integration of three dimensional cell culture scaffolds in microfluidic devices by direct fiber spinning |
| CN107510862B (zh) * | 2016-06-15 | 2020-05-19 | 中国科学院苏州纳米技术与纳米仿生研究所 | 担载梯度浓度生物活性分子的有序纤维支架、制法及应用 |
| CN106178120B (zh) * | 2016-08-05 | 2019-05-03 | 东华大学 | 一种仿生天然血管三层结构的复合材料血管支架及其制备方法 |
| CN106691646B (zh) * | 2016-12-30 | 2019-03-12 | 山东中保康医疗器具有限公司 | 可降解镁合金输尿管支架 |
| CN106726036B (zh) * | 2016-12-30 | 2019-02-05 | 山东中保康医疗器具有限公司 | 可降解镁合金尿道支架 |
| US11678967B2 (en) * | 2017-02-28 | 2023-06-20 | Provasctec Limited | Intravascular cell therapy device |
| JP6967265B2 (ja) * | 2017-04-28 | 2021-11-17 | 株式会社彩 | 医療用基材の評価方法及び製造方法 |
| US20200330646A1 (en) * | 2017-11-17 | 2020-10-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Scaffolds having material properties optimized for cardiac applications and uses thereof |
| CN107715179B (zh) * | 2017-11-24 | 2022-08-26 | 江南大学附属医院 | 复合型人工小血管支架及其制备方法 |
| GB201813461D0 (en) * | 2018-08-17 | 2018-10-03 | Raft Enterprises Ltd | Tissue scaffold |
| JP7669266B2 (ja) * | 2018-08-31 | 2025-04-28 | ウィスコンシン アラムニ リサーチ ファンデーション | 動脈内皮細胞を播種した血管移植片の生成 |
| EP3860560A1 (en) * | 2018-10-01 | 2021-08-11 | The Electrospinning Company Ltd | Membrane |
| WO2022081644A1 (en) * | 2020-10-13 | 2022-04-21 | Nanofiber Solutions, Llc | Kink-resistant electrospun fiber assemblies and methods of making the same |
| CN112915255B (zh) * | 2021-01-20 | 2021-12-03 | 浙江大学 | 一种多尺度生物支架及其制造方法与应用 |
| US20250011716A1 (en) * | 2022-12-22 | 2025-01-09 | Massachusetts Institute Of Technology | Knitted cell scaffolds |
| CN116831780A (zh) * | 2023-07-05 | 2023-10-03 | 北京航空航天大学 | 一种波纹状小口径人造血管及其制造方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0157178B1 (en) * | 1984-03-01 | 1988-11-30 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
| CN85101355A (zh) * | 1985-01-29 | 1987-01-21 | 钟渊化学工业株式会社 | 人造血管及其制做工艺 |
| US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5282847A (en) * | 1991-02-28 | 1994-02-01 | Medtronic, Inc. | Prosthetic vascular grafts with a pleated structure |
| JPH07250887A (ja) * | 1994-03-15 | 1995-10-03 | Seikagaku Kogyo Co Ltd | 人工血管およびその製造方法 |
| EP1582181A3 (en) * | 1994-06-27 | 2010-04-21 | Bard Peripheral Vascular, Inc. | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith |
| US5618718A (en) * | 1994-12-30 | 1997-04-08 | Universite Laval | Production of a contractile smooth muscle |
| US5714359A (en) * | 1995-10-12 | 1998-02-03 | The University Of Akron | Apparatus and method for electrostatic endothelial cell seeding in a vascular prosthesis |
| EP0965310A4 (en) * | 1996-12-06 | 2003-03-19 | Tapic Int Co Ltd | ARTIFICIAL BLOOD VESSEL |
| CA2306346C (en) * | 1997-07-03 | 2010-09-14 | Massachusetts Institute Of Technology | Tissue-engineered tubular construct having circumferentially oriented smooth muscle cells |
| US6852533B1 (en) * | 1998-01-23 | 2005-02-08 | Cornell Research Foundation, Inc. | Purified populations of stem cells |
| US6197043B1 (en) * | 1999-08-18 | 2001-03-06 | James A. Davidson | Isoelastic suture material and device |
| US6503273B1 (en) * | 1999-11-22 | 2003-01-07 | Cyograft Tissue Engineering, Inc. | Tissue engineered blood vessels and methods and apparatus for their manufacture |
| US7175658B1 (en) * | 2000-07-20 | 2007-02-13 | Multi-Gene Vascular Systems Ltd. | Artificial vascular grafts, their construction and use |
| CN1389271A (zh) * | 2001-05-31 | 2003-01-08 | 东华大学 | 针织医用金属内支架及其制造方法 |
| EP1414369A2 (en) * | 2001-07-27 | 2004-05-06 | Medtronic, Inc. | Adventitial fabric reinforced porous prosthetic graft |
| US20040044403A1 (en) * | 2001-10-30 | 2004-03-04 | Joyce Bischoff | Tissue-engineered vascular structures |
| US7575759B2 (en) * | 2002-01-02 | 2009-08-18 | The Regents Of The University Of Michigan | Tissue engineering scaffolds |
| AU2003219916A1 (en) * | 2002-02-22 | 2003-09-09 | University Of Washington | Bioengineered tissue substitutes |
| US7976936B2 (en) * | 2002-10-11 | 2011-07-12 | University Of Connecticut | Endoprostheses |
| WO2004096095A2 (en) * | 2003-04-28 | 2004-11-11 | Medtronic, Inc. | Compliant venous graft |
| US20050131520A1 (en) * | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
| US8192348B2 (en) * | 2003-07-01 | 2012-06-05 | Regents Of The University Of Minnesota | Engineered blood vessels |
| US7377939B2 (en) * | 2003-11-19 | 2008-05-27 | Synecor, Llc | Highly convertible endolumenal prostheses and methods of manufacture |
| JP2005152181A (ja) * | 2003-11-25 | 2005-06-16 | Terumo Corp | 埋込み可能な管状体治療具 |
| CN101060817B (zh) * | 2004-11-19 | 2011-08-03 | 帝人株式会社 | 圆筒体的制造方法 |
| US8048446B2 (en) * | 2005-05-10 | 2011-11-01 | Drexel University | Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds |
| EP1987134A4 (en) * | 2006-02-10 | 2012-08-01 | Tengion Inc | EQUIPMENT FOR ORGANIC DESIGN AND AUGMENTATION |
-
2009
- 2009-02-13 CA CA2715642A patent/CA2715642C/en not_active Expired - Fee Related
- 2009-02-13 JP JP2010546939A patent/JP5632749B2/ja not_active Expired - Fee Related
- 2009-02-13 US US12/371,522 patent/US20090227026A1/en not_active Abandoned
- 2009-02-13 KR KR1020107020398A patent/KR101669292B1/ko not_active Expired - Fee Related
- 2009-02-13 CN CN200980113252.2A patent/CN102006837B/zh not_active Expired - Fee Related
- 2009-02-13 CN CN201410457774.7A patent/CN104248477B/zh not_active Expired - Fee Related
- 2009-02-13 EP EP09711088.6A patent/EP2249742B1/en not_active Not-in-force
- 2009-02-13 WO PCT/US2009/034137 patent/WO2009103012A1/en not_active Ceased
- 2009-02-13 AU AU2009214508A patent/AU2009214508B2/en not_active Ceased
-
2014
- 2014-02-12 JP JP2014024053A patent/JP5978425B2/ja not_active Expired - Fee Related
- 2014-08-06 JP JP2014160094A patent/JP2015006400A/ja not_active Withdrawn
-
2016
- 2016-08-05 JP JP2016154306A patent/JP2016187640A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2249742B1 (en) | 2017-06-21 |
| JP2014094315A (ja) | 2014-05-22 |
| JP2015006400A (ja) | 2015-01-15 |
| KR101669292B1 (ko) | 2016-10-25 |
| CN104248477B (zh) | 2018-02-13 |
| KR20100120686A (ko) | 2010-11-16 |
| CN104248477A (zh) | 2014-12-31 |
| AU2009214508A1 (en) | 2009-08-20 |
| JP5978425B2 (ja) | 2016-08-24 |
| CA2715642A1 (en) | 2009-08-20 |
| HK1155936A1 (en) | 2012-06-01 |
| US20090227026A1 (en) | 2009-09-10 |
| AU2009214508B2 (en) | 2014-11-20 |
| WO2009103012A1 (en) | 2009-08-20 |
| EP2249742A1 (en) | 2010-11-17 |
| HK1206579A1 (en) | 2016-01-15 |
| CA2715642C (en) | 2017-03-28 |
| CN102006837A (zh) | 2011-04-06 |
| JP2011512201A (ja) | 2011-04-21 |
| AU2009214508A2 (en) | 2010-09-23 |
| CN102006837B (zh) | 2014-12-24 |
| JP2016187640A (ja) | 2016-11-04 |
| EP2249742A4 (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5978425B2 (ja) | 組織工学足場 | |
| Jia et al. | Design and comprehensive assessment of a biomimetic tri-layer tubular scaffold via biodegradable polymers for vascular tissue engineering applications | |
| US10751447B2 (en) | Laminous vascular constructs combining cell sheet engineering and electrospinning technologies | |
| Johnson et al. | Coaxially-structured fibres with tailored material properties for vascular graft implant | |
| Zhang et al. | A compliant and biomimetic three-layered vascular graft for small blood vessels | |
| Ju et al. | Bilayered scaffold for engineering cellularized blood vessels | |
| Elliott et al. | Three-dimensional culture of small-diameter vascular grafts | |
| McMahon et al. | Hydrogel–electrospun mesh composites for coronary artery bypass grafts | |
| US20130150947A1 (en) | Scaffold system to repair cardiovascular conditions | |
| Xie et al. | The mechanical performance of weft-knitted/electrospun bilayer small diameter vascular prostheses | |
| CN107073173B (zh) | 用于产生由结合丝丝心蛋白微纤维和纳米纤维组成的混合结构的方法、由此获得的混合结构及其作为可植入医疗装置的用途 | |
| Moreno et al. | Development of a compliant and cytocompatible micro‐fibrous polyethylene terephthalate vascular scaffold | |
| Wang et al. | Nonlinear elasticity of blood vessels and vascular grafts | |
| Yin et al. | Electrospun silk fibroin/poly (L-lactide-ε-caplacton) graft with platelet-rich growth factor for inducing smooth muscle cell growth and infiltration | |
| Liu et al. | Evaluation of mechanical properties and biocompatibility of three-layer PCL/PLLA small-diameter vascular graft with pore diameter gradient | |
| Lee et al. | Tissue-engineered vascular graft based on a bioresorbable tubular knit scaffold with flexibility, durability, and suturability for implantation | |
| Mohapatra et al. | From in vitro to perioperative vascular tissue engineering: shortening production time by traceable textile-reinforcement | |
| AU2014265032A1 (en) | Tissue engineering scaffolds | |
| HK1206579B (en) | Tissue engineering scaffolds | |
| Zhao et al. | Bioscaffolds development for small-diameter vascular grafts | |
| HK1155936B (en) | Tissue engineering scaffolds | |
| Zhang | Studies of Tissue-Engineered Vascular Graft fabricated from Electrochemically Aligned Collagen Yarns and Electrospun Collagen Nanofibers | |
| Doshi | Direct cell seeding on collagen-coated silicone mandrels to generate cell-derived tissue tubes | |
| Campbell | Investigation of small diameter decellularised artery as a potential scaffold for vascular tissue engineering | |
| Balà Palasí | Development of a bioresorbable patch to treat aortic dissection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120210 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130128 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130626 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130705 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131004 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131111 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140515 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140806 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140904 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141001 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141010 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5632749 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |